✦ LIBER ✦

Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor

✍ Scribed by Samama, M. M.; Martinoli, J.-L.; LeFlem, L.; Guinet, C.; Plu-Bureau, G.; Depasse, F.; Perzborn, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromogenic laboratory assays to measure

✍ Richard C. Becker; Hongqiu Yang; Yuchen Barrett; Puneet Mohan; Jessie Wang; Lars 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 374 KB

Effects of the oral, direct factor Xa in

✍ A. HILLARP; F. BAGHAEI; I. FAGERBERG BLIXTER; K. M. GUSTAFSSON; L. STIGENDAL; M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

The discovery and development of rivarox

✍ Perzborn, Elisabeth; Roehrig, Susanne; Straub, Alexander; Kubitza, Dagmar; Misse 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 588 KB

Management consensus guidance for the us

✍ Turpie, A. G. G.; Kreutz, R.; Llau, J.; Norrving, B.; Haas, S. 📂 Article 📅 2012 🏛 Schattauer 🌐 English ⚖ 382 KB

Rivaroxaban: a new orally active direct

✍ Steve Chaplin 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) ⚖ 454 KB

Rivaroxaban – an oral, direct Factor Xa

✍ Sylvia Haas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB